Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).

HOME
>
論文・技術情報
>
Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).

アブストラクト	[This corrects the article DOI: 10.3389/fphar.2025.1561937.].
ジャーナル名	Frontiers in pharmacology
Pubmed追加日	2025/9/25
投稿者	Che, Xinzhen; Zhu, Yong
組織名	First Clinical Medical College, Shandong University of Traditional Chinese;Medicine, Jinan, Shandong, China.;Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan,;Shandong, China.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40994637/